The Evolution of Dasatinib Dosage Over the Years and Its Relevance to Other Anticancer Medications

Cancer - United States
doi 10.1002/cncr.31516
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search